Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Moving the Needle Cautiously in Targeting One of the Most Often Acquired Receptor Tyrosine Fusion (RET Fusion) Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Bibliographic Details
Main Authors: Shannon S. Zhang, MD, Sai-Hong Ignatius Ou, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364322000820

Internet

http://www.sciencedirect.com/science/article/pii/S2666364322000820

Similar Items